MedDataX Logo

ENDOMETRIOSIS - MRI

NCT ID: NCT05779462

Last Updated: 2025-12-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

52 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-05-23

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Endometriosis is a frequent pathology with an estimated prevalence of 10% of women of childbearing age. There is no exact correspondence between the symptoms described by the patients and the severity of the lesions, which makes clinical diagnosis difficult. It therefore seems important to improve the complementary examinations available to make the diagnosis more precise and to better study the effectiveness of the treatments implemented. The clinical examination and per-surgical findings of patients with deep pelvic endometriosis show a clear decrease in the mobility of the pelvic organs in relation to each other, but few studies have looked at this mobility, which could however have an implication in explaining the pathophysiology of the disease and the symptomatology of the patients, as well as in the detection of lesions preoperatively. The persistence of hypo-mobility could also help to understand treatment failures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endometriosis Mobility Limitation Magnetic Resonance Imaging Diagnosis Pelvis Comparative Study

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Endometriosis ; Mobility Limitation Magnetic Resonance Imaging, Cine Pelvis Comparative Study

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with pelvic endometriosis

Patients referred for suspected pelvic endometriosis, with pelvic endometriosis on initial MRI

Dynamic MRI Sequence

Intervention Type OTHER

Addition of a Dynamic MRI Sequence during the MRI examination performed in routine care

patients without pelvic endometriosis

Patients referred for suspected pelvic endometriosis but without endometriosis found on diagnostic MRI.

Dynamic MRI Sequence

Intervention Type OTHER

Addition of a Dynamic MRI Sequence during the MRI examination performed in routine care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dynamic MRI Sequence

Addition of a Dynamic MRI Sequence during the MRI examination performed in routine care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient referred for suspected pelvic endometriosis requiring pelvic MRI
* Female, nulliparous,
* patient with signed written consent, patient with health insurance,
* patient willing to comply with all study procedures and duration

Exclusion Criteria

* BMI \> 35,
* history of hereditary collagen and elastic tissue disease,
* history of pelviperitonitis,
* history of major pelvic surgery,
* inability to receive informed information,
* inability to participate in the entire study,
* lack of social security coverage,
* refusal to sign consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Lille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chrystele RUBOD, MD,PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Lille

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de chirurgie gynécologique Hôpital Jeanne de Flandre - CHU de LILLE

Lille, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chrystele RUBOD, MD,PhD

Role: CONTACT

Phone: 0320445962

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

CHRYSTELE RUBOD DIT GUILLET,

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-A02135-38

Identifier Type: OTHER

Identifier Source: secondary_id

2022_0032

Identifier Type: -

Identifier Source: org_study_id